Unknown

Dataset Information

0

Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis.


ABSTRACT: Currently, no reliable markers are available to evaluate the epileptogenic potential of a brain injury. The electroencephalogram is the standard method of diagnosis of epilepsy; however, it is not used to predict the risk of developing epilepsy. Biomarkers that indicate an individual's risk to develop epilepsy, especially those measurable in the periphery are urgently needed. Temporal lobe epilepsy (TLE), the most common form of acquired epilepsy, is characterized by spontaneous recurrent seizures following brain injury and a seizure-free "latent" period. Elucidation of mechanisms at play during epilepsy development (epileptogenesis) in animal models of TLE could enable the identification of predictive biomarkers. Our pilot study using liquid chromatography-mass spectrometry metabolomics analysis revealed changes (p-value???0.05, ?1.5-fold change) in lipid, purine, and sterol metabolism in rat plasma and hippocampus during epileptogenesis and chronic epilepsy in the kainic acid model of TLE. Notably, disease development was associated with dysregulation of vitamin D3 metabolism at all stages and plasma 25-hydroxyvitamin D3 depletion in the acute and latent phase of injury-induced epileptogenesis. These data suggest that plasma VD3 metabolites reflect the severity of an epileptogenic insult and that a panel of plasma VD3 metabolites may be able to serve as a marker of epileptogenesis.

SUBMITTER: Heischmann S 

PROVIDER: S-EPMC4985632 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis.

Heischmann Svenja S   Quinn Kevin K   Cruickshank-Quinn Charmion C   Liang Li-Ping LP   Reisdorph Rick R   Reisdorph Nichole N   Patel Manisha M  

Scientific reports 20160816


Currently, no reliable markers are available to evaluate the epileptogenic potential of a brain injury. The electroencephalogram is the standard method of diagnosis of epilepsy; however, it is not used to predict the risk of developing epilepsy. Biomarkers that indicate an individual's risk to develop epilepsy, especially those measurable in the periphery are urgently needed. Temporal lobe epilepsy (TLE), the most common form of acquired epilepsy, is characterized by spontaneous recurrent seizur  ...[more]

Similar Datasets

| S-EPMC24239 | biostudies-literature
2022-06-21 | GSE199273 | GEO
| S-EPMC5001725 | biostudies-literature
| S-EPMC8699879 | biostudies-literature
| S-EPMC3125300 | biostudies-literature
| S-EPMC4526455 | biostudies-literature
| S-EPMC9309538 | biostudies-literature
| S-EPMC4529368 | biostudies-literature
| S-EPMC19012 | biostudies-literature
| S-EPMC4380815 | biostudies-literature